New Advancements and Developments in Treatment of Renal Cell Carcinoma: Focus on Pazopanib

OncoTargets and Therapy - New Zealand
doi 10.2147/ott.s12480
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

New Developments in the Treatment of Basal Cell Carcinoma: Update on Current and Emerging Treatment Options With a Focus on Vismodegib

OncoTargets and Therapy
OncologyPharmacology
2018English

Angiotensin Inhibitors as Treatment of Sunitinib/Pazopanib-Induced Hypertension in Metastatic Renal Cell Carcinoma

Clinical Genitourinary Cancer
OncologyUrology
2017English

New Developments in the Treatment of Advanced Squamous Cell Lung Cancer: Focus on Afatinib

OncoTargets and Therapy
OncologyPharmacology
2017English

Pharmacotherapy Options in Advanced Renal Cell Carcinoma: What Role for Pazopanib?

Clinical Medicine Insights: Oncology
Oncology
2011English

Rationale for Targeted Therapies and Potential Role of Pazopanib in Advanced Renal Cell Carcinoma

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2010English

Pazopanib-Induced Liver Toxicity in Metastatic Renal Cell Carcinoma (mRCC) Patients: Impact of UGT1A1 Polymorphism on Pazopanib Dose Reduction, Safety and Patient Outcome

Clinical Genitourinary Cancer
OncologyUrology
2020English

New Developments in the Treatment of Chemotherapy-Induced Neutropenia: Focus on Balugrastim

Therapeutics and Clinical Risk Management
2016English

COMPARZ Post Hoc Analysis: Characterizing Pazopanib Responders With Advanced Renal Cell Carcinoma

Clinical Genitourinary Cancer
OncologyUrology
2019English

New Systemic Approaches in the Treatment of Metastatic Renal Cell Carcinoma

2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy